Nimbus Therapeutics News and Activities

Acquisition, funding and merger involving Nimbus Therapeutics.

• Nimbus Therapeutics has just announced a $55 Million fundraising (posted on January 7 2026).

View the org chart displaying its 24 main executives

Most searched biographies at Nimbus Therapeutics

• Abbas Kazimi, Chief Executive Officer
• Laura Stoppel, Director
• Bruce Booth, Chairman of the Board

Create your alert
to follow the executive moves at Nimbus Therapeutics.

Nimbus Therapeutics has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Nimbus Therapeutics

• News Archive - Nimbus Therapeutics
• After two Big Pharma deals, Nimbus looks to keep the hits coming
• Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this year
• Takeda’s $4 Billion Psoriasis Pill Helped Clear Skin in Mid-Stage Study
• Nimbus CEO Jeb Keiper on negotiating a $4B deal and building an unorthodox biotech startup
• Nimbus raises $125M to advance rival to Bristol Myers’ new psoriasis drug
• UNCF Virtual Summit to Create Pathways for African American Opportunities in the Greater Boston Area Life Sciences Ecosystem | UNCF
• View more press releases Close

Social media about Nimbus Therapeutics

• Nimbus Therapeutics on Wikipedia, Google News & Yahoo Finance
• Nimbus Therapeutics on LinkedIn, X (Twitter) & YouTube